Moneycontrol
Get App
Last Updated : Feb 21, 2017 08:25 AM IST | Source: CNBC-TV18

Starting to design clinical studies in India: Novartis

Global drug major Novartis has invested, expanded its research & development (R&D) capabilities in India. The global leader in biosimilars through its subsidiary Sandoz is assessing Indian market dynamics to launch its portfolio.

Global drug major Novartis has invested, expanded its research & development (R&D) capabilities in India. The global leader in biosimilars through its subsidiary Sandoz is assessing Indian market dynamics to launch its portfolio. Novartis' global head of drug development, Vas Narasimhan, says that India is still some time away to see investments in basic drug discovery.

Also watch Patrick Vallance, President-R&D at GSK and Paul Stoffels of Johnson & Johnson sharing their views on R&D challenges in India.

Watch videos for entire conversation.....
First Published on Feb 10, 2017 04:28 pm
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant